A targeted gene expression biomarker predicts clinic low-risk meningioma recurrence. Nguyen MP, Morshed RA, Youngblood MW, Perlow HK, et al. Neuro Oncol 2024 Sep 28:noae198. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Nguyen MP, Morshed RA, Youngblood MW, Perlow HK, et al. A targeted gene expression biomarker predicts clinic low-risk meningioma recurrence. Neuro Oncol 2024 Sep 28:noae198. doi: 10.1093.
PMID: 39340366